7 unknown. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 7 |
| Phase 1 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Interferon alpha-2: new trials by email Literature Review of Interferon alpha-2 trials Research Report on Interferon alpha-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer Tumor Infiltrating Lymphocytes (TIL), Interferon Alfa 2A, Carboplatin - Ovarian Cancer Recurrent | Phase 1 / Phase 2 | Unknown | Leiden University Medical Center | 12 | 2018-08-01 | 2021-04-01 |
| Interferon-α After DLI for the Prevention of Relapse Interferon Alfa-2b - Leukemia | Phase 1 / Phase 2 | Unknown | Peking University People's Hospital | 42 | 2015-12-01 | 2016-09-29 |
| Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer Interleukin-2, Interferon Alfa-2b, Bevacizumab - Metastatic Renal Cell Carcinoma | Phase 2 | Unknown | University of Aarhus | 118 | 2009-10-01 | 2014-12-02 |
| Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients CSF470 vaccine, BCG, Molgramostim, interferon alpha 2b - Cutaneous Melanoma | Phase 2 / Phase 3 | Unknown | Laboratorio Pablo Cassara S.R.L. | 108 | 2009-04-01 | 2015-09-02 |
| MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer bevacizumab, recombinant interferon alpha-2a - Kidney Cancer | Phase 2 | Unknown | Mount Vernon Cancer Centre at Mount Vernon Hospital | 30 | 2008-04-01 | 2013-08-12 |
| Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer Heckel Infrared Radiant Heat Device, cisplatin, gemcitabine, interferon-alpha, thermochemotherapy - Pancreatic Neoplasms | Phase 2 | Unknown | The University of Texas Health Science Center, Houston | 36 | 2003-09-01 | 2011-03-03 |
| Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha Aricept, IFN-alpha2A - Memory Disorders, Alzheimer's Disease | Phase 2 | Unknown | National Center for Research Resources (NCRR) | 2008-02-05 |
Carcinoma, Renal Cell (2) · Alzheimer Disease (1) · Atherosclerosis (1) · Autoimmune Diseases (1) · Inflammation (1) · Kidney Neoplasms (1) · Leukemia (1) · Melanoma (1) · Memory Disorders (1) · Neoplasms (1) · Pancreatic Neoplasms (1) · Recurrence (1)
Laboratorio Pablo Cassara S.R.L. (1) · Leiden University Medical Center (1) · Mount Vernon Cancer Centre at Mount Vernon Hospital (1) · National Center for Research Resources (NCRR) (1) · Peking University People's Hospital (1) · The University of Texas Health Science Center, Houston (1) · University of Aarhus (1)
United States (2) · Argentina (1) · China (1) · Denmark (1) · Netherlands (1) · United Kingdom (1)
Frede Donskov, MD, DMSc (1) · Joan M Bull, M.D. (1) · Judith Kroep, MD, PhD (1) · Paul Nathan, MD (1) · Poul Geertsen, MD, PhD (1)
PMID 28620382, PMID 29392960, PMID 29774030, PMID 34327591, PMID 37146227